HealthQuill fatty liver disease
Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and commercialising of the Chinese company’s “triple G” weight-loss candidate.
Drugs Medical Pharma

Novo Nordisk in $2b deal with Chinese firm for ‘triple-G’ obesity drug

HQ Team February 25, 2025: Novo Nordisk has inked a $2 billion licensing pact with United Laboratories International for the development, manufacturing and.

Read More
The Hepatitis C virus wears a “mask” and remains hidden to evade the human immune system to cause inflammation and scarring of the liver, Dutch researchers found.
Drugs Health Medical

‘Fatty liver progression to liver cancer is common occurrence’, say researchers

HQ Team January 2, 2025: Scientists at the University of California San Diego School of Medicine have made deeper inroads in understanding the.

Read More